National Treasure Signs $200 Million Mask Export Contract to US with EDGC and SkyBio

"Overseas Inquiries Flood In... Future Expansion of Supply Areas Expected"

From the left, Jaechang Lim, CEO of SkyBio, Hyun Ha, CEO of Gukbo, and Myunghee Lee, CEO of EDGC Healthcare (Provided by Gukbo)

[Asia Economy Reporter Minwoo Lee] KOSPI-listed company Gukbo has signed a $200 billion export contract for quarantine masks to the United States together with EDGC Healthcare and SkyBio.

Gukbo announced on the 23rd that it has signed a contract to supply KF-type quarantine masks to national and private institutions across the United States. The contract amount is 204 billion KRW, which is about 350% of last year's sales. Gukbo and SkyBio will supply KF-type quarantine masks to EDGC Healthcare, which will handle registration of delivery institutions and other tasks.

Earlier, on the 15th, Gukbo acquired 32 KF-type mask production facilities. They plan to continuously increase the number of KF-type mask production facilities to 100. Once the mask production facilities currently being prepared are completed, it is explained that they will be able to supply more than 15 million masks per month. A Gukbo official said, "Recently, 36 states in the U.S. have mandated mask-wearing in public places and multi-use facilities, so demand for masks in the U.S. is expected to surge," adding, "Inquiries about KF quarantine masks from overseas companies continue, so we expect sales to increase in the mid to long term."

Hyun Ha, CEO of Gukbo, emphasized, "This contract is a great meeting of Gukbo, a comprehensive logistics company with 67 years of tradition and history, SkyBio's outstanding technology, and EDGC Healthcare's global network and partnership," adding, "It will greatly contribute to promoting the excellence of Korea's quarantine efforts worldwide and overcoming the COVID-19 pandemic."

This content was produced with the assistance of AI translation services.